JP2018536433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018536433A5 JP2018536433A5 JP2018541546A JP2018541546A JP2018536433A5 JP 2018536433 A5 JP2018536433 A5 JP 2018536433A5 JP 2018541546 A JP2018541546 A JP 2018541546A JP 2018541546 A JP2018541546 A JP 2018541546A JP 2018536433 A5 JP2018536433 A5 JP 2018536433A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- hbv
- nucleotide sequence
- antigenic fragment
- arenavirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021116562A JP2021182922A (ja) | 2015-11-04 | 2021-07-14 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2023180121A JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250639P | 2015-11-04 | 2015-11-04 | |
| US62/250,639 | 2015-11-04 | ||
| PCT/EP2016/076591 WO2017076988A1 (en) | 2015-11-04 | 2016-11-03 | Vaccines against hepatitis b virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021116562A Division JP2021182922A (ja) | 2015-11-04 | 2021-07-14 | Ｂ型肝炎ウイルスに対するワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018536433A JP2018536433A (ja) | 2018-12-13 |
| JP2018536433A5 true JP2018536433A5 (enExample) | 2020-03-26 |
| JP6914950B2 JP6914950B2 (ja) | 2021-08-11 |
Family
ID=57249796
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541546A Active JP6914950B2 (ja) | 2015-11-04 | 2016-11-03 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2021116562A Pending JP2021182922A (ja) | 2015-11-04 | 2021-07-14 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2023180121A Active JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021116562A Pending JP2021182922A (ja) | 2015-11-04 | 2021-07-14 | Ｂ型肝炎ウイルスに対するワクチン |
| JP2023180121A Active JP7777907B2 (ja) | 2015-11-04 | 2023-10-19 | Ｂ型肝炎ウイルスに対するワクチン |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11214598B2 (enExample) |
| EP (2) | EP4177348A1 (enExample) |
| JP (3) | JP6914950B2 (enExample) |
| KR (2) | KR20250107977A (enExample) |
| CN (2) | CN108779472B (enExample) |
| AU (2) | AU2016348675B2 (enExample) |
| CA (1) | CA3003557A1 (enExample) |
| DK (1) | DK3371316T3 (enExample) |
| ES (1) | ES2934698T3 (enExample) |
| FI (1) | FI3371316T3 (enExample) |
| HR (1) | HRP20221474T1 (enExample) |
| HU (1) | HUE060648T2 (enExample) |
| IL (2) | IL314371A (enExample) |
| LT (1) | LT3371316T (enExample) |
| MX (2) | MX2018005569A (enExample) |
| PL (1) | PL3371316T3 (enExample) |
| PT (1) | PT3371316T (enExample) |
| SG (1) | SG11201803474UA (enExample) |
| SI (1) | SI3371316T1 (enExample) |
| WO (1) | WO2017076988A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20221475T3 (hr) | 2007-12-27 | 2023-01-06 | Universität Zürich | Replikacijski defektni vektori arenavirusa |
| LT3077519T (lt) | 2013-12-03 | 2021-04-26 | Hookipa Biotech Gmbh | Cmv vakcinos |
| RS60937B1 (sr) | 2014-11-13 | 2020-11-30 | Univ Geneve | Tri-segmentirani arenavirusi kao vektori za vakcinu |
| JP7098330B2 (ja) | 2015-06-10 | 2022-07-11 | ホオキパ バイオテック ジーエムビーエイチ | Ｈｐｖワクチン |
| ES2934698T3 (es) * | 2015-11-04 | 2023-02-24 | Hookipa Biotech Gmbh | Vacunas contra el virus de la hepatitis B |
| CA3003548A1 (en) | 2015-11-12 | 2017-05-18 | Hookipa Biotech Ag | Arenavirus particles as cancer vaccines |
| US10662416B2 (en) | 2016-10-14 | 2020-05-26 | Precision Biosciences, Inc. | Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome |
| JP2022010188A (ja) * | 2017-02-03 | 2022-01-14 | 株式会社三洋物産 | 遊技機 |
| JP2022010187A (ja) * | 2017-02-03 | 2022-01-14 | 株式会社三洋物産 | 遊技機 |
| US11020476B2 (en) | 2017-12-19 | 2021-06-01 | Janssen Sciences Ireland Unlimited Company | Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV) |
| US11021692B2 (en) | 2017-12-19 | 2021-06-01 | Janssen Sciences Ireland Unlimited Company | Hepatitis B virus (HBV) vaccines and uses thereof |
| US11389531B2 (en) | 2017-12-19 | 2022-07-19 | Janssen Sciences Ireland Unlimited Company | Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines |
| WO2019195181A1 (en) | 2018-04-05 | 2019-10-10 | Gilead Sciences, Inc. | Antibodies and fragments thereof that bind hepatitis b virus protein x |
| TW201945388A (zh) | 2018-04-12 | 2019-12-01 | 美商精密生物科學公司 | 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶 |
| AU2020297011A1 (en) | 2019-06-18 | 2022-02-10 | Janssen Sciences Ireland Unlimited Company | Arenavirus vectors for hepatitis B virus (HBV) vaccines and uses thereof |
| US20220296703A1 (en) * | 2019-06-18 | 2022-09-22 | Janssen Sciences Ireland Unlimited Company | Cobmination of hepatitis b virus (hbv) vaccines and anti-pd-1 or anti-pd-l1 antibody |
| WO2020263830A1 (en) | 2019-06-25 | 2020-12-30 | Gilead Sciences, Inc. | Flt3l-fc fusion proteins and methods of use |
| LT4037708T (lt) * | 2019-09-30 | 2024-11-25 | Gilead Sciences, Inc. | Hbv vakcinos ir hbv gydymo būdai |
| US20220380805A1 (en) * | 2019-11-07 | 2022-12-01 | Universität Basel | Arenaviruses as vectors |
| FI4069729T3 (fi) | 2019-12-06 | 2025-04-01 | Prec Biosciences Inc | Optimoidut muokatut meganukleaasit, joilla on spesifisyys tunnistussekvenssiä varten hepatiitti b -virusgenomissa |
| KR20220131918A (ko) | 2019-12-24 | 2022-09-29 | 카나 바이오사이언스, 인코포레이션 | 다이아실글리세롤 키나제 조절 화합물 |
| EP4121437A1 (en) | 2020-03-20 | 2023-01-25 | Gilead Sciences, Inc. | Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same |
| KR102375703B1 (ko) | 2020-07-28 | 2022-03-17 | 경북대학교 산학협력단 | 사물 인터넷 환경에서 CoAP 기반의 데이터 스트리밍 방법 및 통신 시스템 |
| US20240174724A1 (en) | 2021-03-23 | 2024-05-30 | Hookipa Biotech Gmbh | Arenaviruses used in treatments of prostate cancer |
| WO2022226242A1 (en) * | 2021-04-21 | 2022-10-27 | La Jolla Institute For Immunology | Engineered arenavirus glycoprotein compositions, methods and use thereof |
| CN113201051B (zh) * | 2021-04-27 | 2022-08-02 | 复旦大学 | 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用 |
| JP2024518558A (ja) | 2021-05-13 | 2024-05-01 | ギリアード サイエンシーズ， インコーポレイテッド | ＴＬＲ８調節化合物と抗ＨＢＶ ｓｉＲＮＡ治療薬との組合せ |
| CA3222439A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| AU2022297367B2 (en) | 2021-06-23 | 2025-04-10 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| PE20242071A1 (es) | 2021-06-23 | 2024-10-18 | Gilead Sciences Inc | Compuestos moduladores de diacilglicerol quinasa |
| US11976072B2 (en) | 2021-06-23 | 2024-05-07 | Gilead Sciences, Inc. | Diacylglycerol kinase modulating compounds |
| WO2025056782A1 (en) | 2023-09-15 | 2025-03-20 | Hookipa Biotech Gmbh | Arenavirus formulations, methods and uses thereof |
| WO2025240246A1 (en) | 2024-05-13 | 2025-11-20 | Gilead Sciences, Inc. | Combination therapies with ribavirin |
| US20250345389A1 (en) | 2024-05-13 | 2025-11-13 | Gilead Sciences, Inc. | Combination therapies |
| WO2025240242A1 (en) | 2024-05-13 | 2025-11-20 | Gilead Sciences, Inc. | Combination therapies with ribavirin |
| WO2025240244A1 (en) | 2024-05-13 | 2025-11-20 | Gilead Sciences, Inc. | Combination therapies comprising bulevirtide and lonafarnib for use in the treatment of hepatitis d virus infection |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722840A (en) * | 1984-09-12 | 1988-02-02 | Chiron Corporation | Hybrid particle immunogens |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| JPH1084967A (ja) | 1996-09-19 | 1998-04-07 | Fujirebio Inc | Ｂ型肝炎のｅ抗原 |
| EP2351768B1 (en) * | 1998-12-04 | 2014-06-18 | Biogen Idec MA Inc. | HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| FR2803599B1 (fr) * | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| US20100183652A1 (en) * | 2002-02-21 | 2010-07-22 | Mark Page | STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| EP1888622A1 (en) | 2005-05-23 | 2008-02-20 | Oxxon Therapeutics Ltd. | Compositions for inducing an immune response against hepatitis b |
| CN101037476A (zh) * | 2006-03-15 | 2007-09-19 | 复旦大学 | 一种用于制备抗体化乙肝疫苗的融合蛋白及其载体 |
| EP2010537B1 (en) | 2006-03-23 | 2011-12-28 | Novartis AG | Imidazoquinoxaline compounds as immunomodulators |
| US8063063B2 (en) | 2006-03-23 | 2011-11-22 | Novartis Ag | Immunopotentiating compounds |
| SI2079760T1 (sl) * | 2006-12-27 | 2016-11-30 | Emory University | Sestavki in metode za zdravljenje okužb |
| HRP20221475T3 (hr) | 2007-12-27 | 2023-01-06 | Universität Zürich | Replikacijski defektni vektori arenavirusa |
| US10076570B2 (en) * | 2009-08-07 | 2018-09-18 | Transgene S.A. | Composition for treating HBV infection |
| WO2011015656A2 (en) * | 2009-08-07 | 2011-02-10 | Transgene Sa | Composition for treating hbv infection |
| CA2827150C (en) * | 2011-02-12 | 2018-09-11 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis b infection |
| WO2012162428A1 (en) | 2011-05-23 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prime-boost vaccination for viral infection |
| IN2014DN06118A (enExample) | 2012-01-24 | 2015-08-14 | Sanford Res Usd | |
| EP2968506B1 (en) | 2013-03-15 | 2019-07-31 | Université de Genève | Anti-mycobacterial vaccines |
| GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
| LT3077519T (lt) | 2013-12-03 | 2021-04-26 | Hookipa Biotech Gmbh | Cmv vakcinos |
| WO2015183895A1 (en) | 2014-05-27 | 2015-12-03 | University Of Rochester | Novel arenavirus vaccine |
| US9943585B2 (en) | 2014-07-30 | 2018-04-17 | University Of Rochester | Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV) |
| JP6875274B6 (ja) | 2014-09-22 | 2021-06-30 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ピチンデウイルスのリバースジェネティクス系及び使用方法 |
| GB201419572D0 (en) | 2014-11-03 | 2014-12-17 | Pirbright Inst The | Virus |
| RS60937B1 (sr) | 2014-11-13 | 2020-11-30 | Univ Geneve | Tri-segmentirani arenavirusi kao vektori za vakcinu |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| JP7098330B2 (ja) | 2015-06-10 | 2022-07-11 | ホオキパ バイオテック ジーエムビーエイチ | Ｈｐｖワクチン |
| ES3021881T3 (en) | 2015-10-23 | 2025-05-27 | Pasteur Institut | Recombinant mopeia virus and vaccine platform |
| ES2934698T3 (es) * | 2015-11-04 | 2023-02-24 | Hookipa Biotech Gmbh | Vacunas contra el virus de la hepatitis B |
| CA3003548A1 (en) | 2015-11-12 | 2017-05-18 | Hookipa Biotech Ag | Arenavirus particles as cancer vaccines |
| US10980877B2 (en) | 2016-04-28 | 2021-04-20 | The University Of Chicago | Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen |
| KR20240095333A (ko) | 2016-05-18 | 2024-06-25 | 유니버시타트 바셀 | 백신 벡터로서 3개의 세그먼트를 가진 피친드 바이러스 |
| EP3534943A2 (en) | 2016-11-04 | 2019-09-11 | Hookipa Biotech GmbH | Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccines |
| WO2018185307A1 (en) | 2017-04-07 | 2018-10-11 | Hookipa Biotech Ag | Arenavirus particles to treat solid tumors |
-
2016
- 2016-11-03 ES ES16791573T patent/ES2934698T3/es active Active
- 2016-11-03 PL PL16791573.5T patent/PL3371316T3/pl unknown
- 2016-11-03 SI SI201631654T patent/SI3371316T1/sl unknown
- 2016-11-03 DK DK16791573.5T patent/DK3371316T3/da active
- 2016-11-03 CN CN201680077751.0A patent/CN108779472B/zh active Active
- 2016-11-03 EP EP22201924.2A patent/EP4177348A1/en active Pending
- 2016-11-03 MX MX2018005569A patent/MX2018005569A/es unknown
- 2016-11-03 HR HRP20221474TT patent/HRP20221474T1/hr unknown
- 2016-11-03 CA CA3003557A patent/CA3003557A1/en active Pending
- 2016-11-03 EP EP16791573.5A patent/EP3371316B1/en active Active
- 2016-11-03 AU AU2016348675A patent/AU2016348675B2/en active Active
- 2016-11-03 JP JP2018541546A patent/JP6914950B2/ja active Active
- 2016-11-03 CN CN202211051785.6A patent/CN115948467A/zh active Pending
- 2016-11-03 IL IL314371A patent/IL314371A/en unknown
- 2016-11-03 IL IL259077A patent/IL259077B2/en unknown
- 2016-11-03 KR KR1020257022585A patent/KR20250107977A/ko active Pending
- 2016-11-03 WO PCT/EP2016/076591 patent/WO2017076988A1/en not_active Ceased
- 2016-11-03 HU HUE16791573A patent/HUE060648T2/hu unknown
- 2016-11-03 KR KR1020187015548A patent/KR102832178B1/ko active Active
- 2016-11-03 US US15/773,512 patent/US11214598B2/en active Active
- 2016-11-03 SG SG11201803474UA patent/SG11201803474UA/en unknown
- 2016-11-03 FI FIEP16791573.5T patent/FI3371316T3/fi active
- 2016-11-03 LT LTEPPCT/EP2016/076591T patent/LT3371316T/lt unknown
- 2016-11-03 PT PT167915735T patent/PT3371316T/pt unknown
-
2018
- 2018-05-03 MX MX2023013140A patent/MX2023013140A/es unknown
-
2021
- 2021-07-14 JP JP2021116562A patent/JP2021182922A/ja active Pending
- 2021-11-24 US US17/535,121 patent/US20220073568A1/en not_active Abandoned
-
2023
- 2023-01-10 AU AU2023200108A patent/AU2023200108B2/en active Active
- 2023-10-19 JP JP2023180121A patent/JP7777907B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018536433A5 (enExample) | ||
| JP2021182922A5 (enExample) | ||
| FI3371316T3 (fi) | Rokotteita hepatiitti b -virusta vastaan | |
| JP6227094B2 (ja) | 複製欠損アレナウイルスベクター | |
| Hanke et al. | Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime | |
| Sominskaya et al. | Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes | |
| JP2019519252A5 (enExample) | ||
| JP2017503482A5 (enExample) | ||
| JP2017535267A5 (enExample) | ||
| JP2017527557A5 (enExample) | ||
| Woo et al. | Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes | |
| JP2017515508A5 (enExample) | ||
| Raji et al. | Virus-like particles in poultry disease: an approach to effective and safe vaccination | |
| JP2000154152A (ja) | 肝炎療剤 | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| Krüger et al. | Chimeric virus-like particles as vaccines | |
| NZ781654B2 (en) | Vaccines against hepatitis b virus | |
| CN1108306A (zh) | 羧端带有前表面抗原1决定簇的重组乙肝疫苗 | |
| Kosinska et al. | MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination | |
| Thomson et al. | Genetically modified hepatitis B surface antigen: A powerful vaccine technology for the delivery of disease-associated foreign antigens | |
| Chen et al. | HBsAg-vectored DNA vaccines elicit concomitant protective responses to multiple CTL epitopes relevant in human disease. | |
| Prince et al. | Methodology Used in DNA-Based Prophylactic and Therapeutic Immunization Against Hepatitis B Virus in Chimpanzees | |
| CN110055228A (zh) | 用于乙肝病毒感染的重组巨细胞病毒与应用 | |
| HK1192456A (en) | Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same | |
| HK1151829B (en) | Replication-defective arenavirus vectors |